Catalyst Wire Dossier Catalyst Wire Dossier

HULIO

ADALIMUMAB-FKJP · Biocon Biologics Inc
Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for HULIO, covering 2020-07-06 to 2026-08-27. Get the full timeline:

Most recent: EMA Authorised: Hulio (adalimumab) — Biosimilar Collaborations Ireland Limited

See pricing